AIM IMMUNOTECH
AIM ImmunoTech is an immuno-pharmaceutical company based in Ocala, Florida. Its expertise is in the development of therapeutics for treating cancers and immune-deficiency disorders. As a result, they have developed strong laboratory and clinical data in relation to the development of nucleic acids and natural interferon to enhance the natural antiviral defence system of the human body and aid in the development of therapeutic products designed to treat cancer and chronic diseases. The company is committed to finding co-development partners with the capital and expertise to commercialize the many potential therapeutic aspects of Ampligen.
AIM IMMUNOTECH
Industry:
Biopharma Biotechnology Health Care
Founded:
1990-01-01
Address:
Orlando, Florida, United States
Country:
United States
Website Url:
http://www.aimimmuno.com
Total Employee:
11+
Status:
Active
Contact:
+1 352 448 7797
Email Addresses:
[email protected]
Total Funding:
5.3 M USD
Technology used in webpage:
Domain Not Resolving Euro
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-03 | AIM ImmunoTech Appoints Robert Dickey, IV as Chief Financial Officer |
Official Site Inspections
http://www.aimimmuno.com Semrush global rank: 7 M Semrush visits lastest month: 939
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AIM ImmunoTech"
Company Info - AIM ImmunoTech
AIM ImmunoTech 2117 SW Highway 484 Ocala, FL 34473 Phone: 352-448-7797 Fax: 352-480-4620 Email: [email protected]See details»
AIM ImmunoTech Issues Notice that an Unaffiliated Third Party …
OCALA, Fla., July 18, 2023 — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued a notice that the Company has learned that unknown person(s) …See details»
AIM ImmunoTech - LinkedIn
AIM ImmunoTech Inc., an immuno-pharma company headquartered in Ocala, Florida, is focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune ...See details»
AIM ImmunoTech Inc. (AIMI) company profile and facts - Yahoo …
See the company profile for AIM ImmunoTech Inc. (AIMI), including business summary, industry/sector information, number of employees, corporate governance, key executives and …See details»
AIM Immunotech Inc. | Insights
Mar 4, 2021 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
AIM ImmunoTech LEI 549300BYFRN3JS60MY33 - Cbonds.com
AIM ImmunoTech. Information about the issuer. News and credit ratings. (LEI 549300BYFRN3JS60MY33). Tables with accounting and financial reporting.See details»
AIM ImmunoTech - Craft
Oct 29, 2024 AIM ImmunoTech (formerly known as Hemispherx Biopharma) is an immuno-tech company focused on the research and development of immunological agents to treat multiple …See details»
AIM ImmunoTech Inc Locations - Headquarters & Offices
Save hours of research time with a comprehensive Sales Intelligence Solution. Understand how AIM ImmunoTech Inc fits into your total addressable market and Ideal Customer Profile.See details»
AIM ImmunoTech Announces Commencement of Phase 2 Study …
Jul 20, 2022 For more information, please visit aimimmuno.com and connect with the Company on Twitter, LinkedIn, and Facebook. About Amarex Clinical Research LLC. Amarex Clinical …See details»
AIM ImmunoTech - Overview, News & Similar companies
May 31, 2024 AIM ImmunoTech contact info: Phone number: (352) 448-7797 Website: www.aimimmuno.com What does AIM ImmunoTech do? AIM ImmunoTech Inc. is an immuno …See details»
Peter Rodino - Chief Operating Officer, General Counsel
Jul 18, 2024 p***@aimimmuno.com. Engage via Phone (***) ***-**** Engage via Mobile (***) ***-**** Reveal Information. Peter Rodino Current Workplace. Company. AIM ImmunoTech. …See details»
AIM ImmunoTech Inc. (AIMI)
2 days ago aimimmuno.com . 21. Full Time Employees. December 31. Fiscal Year Ends. Healthcare. Sector. Biotechnology. Industry. More about AIM ImmunoTech Inc. Performance …See details»
AIM announces Paul Goepfert, MD, as the principal investigator …
Feb 28, 2025 AIM has engaged Amarex Clinical Research, its Clinical Research Organization, with the preparation of an Investigational New Drug application and the eventual management …See details»
AIM ImmunoTech’s Drug Ampligen to Be Tested by Japan’s …
Mar 9, 2020 OCALA, FL / ACCESSWIRE / March 9, 2020 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of …See details»
AIM announces Paul Goepfert, MD, as the principal investigator …
Feb 28, 2025 AIM has engaged Amarex Clinical Research, its Clinical Research Organization, with the preparation of an Investigational New Drug application and the eventual management …See details»
AIM ImmunoTech announces a planned follow-up clinical study
Feb 7, 2025 AIM has engaged Amarex Clinical Research (“Amarex”), its Clinical Research Organization (“CRO”), with the application and eventual management of a follow-up …See details»
AIM ImmunoTech Outlines Recent Progress Across Clinical
Feb 29, 2024 To stay up to date with the Company’s activities visit aimimmuno.com and connect with the Company on X, LinkedIn, and Facebook. About AIM ImmunoTech Inc. AIM …See details»
AIM ImmunoTech Provides Progress on Advancement of …
OCALA, Fla., April 12, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and …See details»
AIM ImmunoTech Reports First Quarter 2024 Financial Results and ...
May 16, 2024 AIM ImmunoTech 2117 SW Highway 484 Ocala, FL 34473 Phone: 352-448-7797 Fax: 352-480-4620 Email: [email protected]See details»
AIM ImmunoTech Enrolls and Doses First Subject in Phase 2
Oct 7, 2023 The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments and cures for myalgic …See details»